| Xu, Wei |
NCT06708156: The Effectiveness and Safety of Two Low-concentration Atropine Sulfate Eye Drops (0.01%/0.02%) for Delaying the Pediatric Myopia Progression |
|
|
| Recruiting | 3 | 606 | RoW | Atropine sulfate eye drops 0.01%, Atropine sulfate eye drops 0.02%, Placebo eye drops | Oupushifang Pharmaceutical Technology Co., Ltd., Seefunge Pharmaceutical Technology Co., Ltd., AUTEK China Inc. | Myopia, Myopia Progression | 12/26 | 12/27 | | |
NCT05931263: A Randomized Clinical Trial Comparing Chi-BEAM With BEAM Regimen Combined With ASCT for the Treatment of ND PTCL |
|
|
| Recruiting | 3 | 104 | RoW | C-BEAM Regimen, BEAM Regimen | The First Affiliated Hospital with Nanjing Medical University | Newly Diagnosed Peripheral T-cell Lymphoma | 02/26 | 02/28 | | |
ICP-CL-01203, NCT06378138: ICP-248 in Combination With Orelabrutinib in Treatment-naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma |
|
|
| Recruiting | 2/3 | 226 | RoW | ICP-248, Orelabrutinib | Beijing InnoCare Pharma Tech Co., Ltd. | Hematologic Malignancies | 11/30 | 07/31 | | |
NCT04423926: Lenalidomide in Combination With CHOP in Patients With Untreated PTCL |
|
|
| Recruiting | 2 | 91 | RoW | Lenalidomide, Cyclophosphamide, Doxorubicin, Vincristine, Prednisolone | The First Affiliated Hospital with Nanjing Medical University | PTCL, NOS, AITL, ALK- ALCL, Phase III-IV ALK+ ALCL, EATL | 12/22 | 12/24 | | |
| Completed | 2 | 3 | RoW | ICP-022 | Beijing InnoCare Pharma Tech Co., Ltd. | Diffuse Large B Cell Lymphoma | 11/21 | 12/21 | | |
NCT05241132: Tislelizumab Combined With Chemotherapy in the Treatment of Bone Metastases of Unknown Primary |
|
|
| Recruiting | 2 | 27 | RoW | Tislelizumab plus chemotherapy, Cisplatin, Paclitaxel | Wei Xu | Cancer of Unknown Primary, Bone Cancer Metastatic, Tislelizumab, Gene Mutation-Related Cancer, Immune Evasion, Tumor, Chemotherapy Effect | 06/23 | 10/24 | | |
NCT04181489: Sintilimab in Combination With R-CHOP in Patients With Treatment-naive EBV-positive DLBCL, NOS |
|
|
| Recruiting | 2 | 55 | RoW | Sintilimab, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisolone | The First Affiliated Hospital with Nanjing Medical University | EBV-Positive DLBCL, Nos | 12/23 | 12/23 | | |
NCT05186558: Penpulimab Plus R2-GemOx Regimen in Relapsed or Refractory DLBCL |
|
|
| Not yet recruiting | 2 | 54 | RoW | penpulimab, lenalidomide, Rituximab, Gemcitabine, Oxaliplatin, lenalidomide, Rituximab, Gemcitabine, Oxaliplatin | The First Affiliated Hospital with Nanjing Medical University | Lymphoma, Large B-Cell, Diffuse, Neoplasms by Histologic Type | 01/24 | 02/26 | | |
NCT05716087: A Study of Rocbrutinib in Participants with Relapse or Refractory Mantle Cell Lymphoma |
|
|
| Active, not recruiting | 2 | 62 | RoW | Rocbrutinib, NWP-775, LP-168 | Guangzhou Lupeng Pharmaceutical Company LTD. | Mantle Cell Lymphoma (MCL) | 12/24 | 12/25 | | |
NCT06594432: Molecular Subtype-Guided R-CHOP-MTX±Zanubrutinib Treatment in Newly Diagnosed DLBCL Patients with Central Nervous System Involvement |
|
|
| Not yet recruiting | 2 | 40 | RoW | R-CHOP+Z+MTX, R-CHOP+MTX | The First Affiliated Hospital with Nanjing Medical University | Diffuse Large B Cell Lymphoma (DLBCL) | 12/26 | 06/27 | | |
NCT04432714: Lenalidomide in Combination With R-DA-EPOCH in Patients With Untreated DLBCL With MYC Rearrangement |
|
|
| Recruiting | 2 | 81 | RoW | Lenalidomide, Rituximab, Etoposide, Doxorubicin, Vincristine, Cyclophosphamide, Prednisone | The First Affiliated Hospital with Nanjing Medical University | DLBCL, Untreated, MYC Gene Rearrangement | 12/24 | 12/26 | | |
NCT04808570: A Study of TQ-B3525 in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma |
|
|
| Terminated | 1/2 | 23 | RoW | TQ-B3525 tablets | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | 11/23 | 11/23 | | |
NCT05323201: Study Of B7H3 CAR-T Cells in Treating Advanced Liver Cancer |
|
|
| Recruiting | 1/2 | 15 | RoW | fhB7H3.CAR-Ts, B7H3 targeting chimeric antigen receptor T cells, Fludarabine, FLUDARA, Cyclophosphamide, Cytoxan | The Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, IIT MediTech Co. Ltd | Hepatocellular Carcinoma | 02/24 | 02/27 | | |
TEACH, NCT04281420: A Study of Evaluating Dual Inhibitor of PAK4 and NAMPT ATG-019 in Advanced Solid Tumors or Non-Hodgkin's Lymphoma |
|
|
| Terminated | 1 | 20 | RoW | ATG-019, KPT-9274, ATG-019 + Niacin ER | Antengene Therapeutics Limited | Solid Tumor, Non-Hodgkin's Lymphoma | 10/23 | 10/23 | | |
TT01488CN02, NCT05683717: A Phase 1 Study to Evaluate the Safety and Tolerability of TT-01488 in Patients With B-Cell Malignancies |
|
|
| Recruiting | 1 | 37 | RoW | TT-01488 Tablets | TransThera Sciences (Nanjing), Inc. | B-Cell Malignancies | 10/26 | 10/28 | | |
NCT05173467: Robot-assisted Invasion-controlled Surgery Versus Traditional-open Surgery Against Metastatic Spinal Tumor |
|
|
| Not yet recruiting | N/A | 60 | RoW | Robot-assisted Invasion-controlled Surgery, Traditional-open Surgery | Wei Xu | Minimally Invasive Surgery, Spinal Metastases | 12/22 | 12/23 | | |
NCT04432402: Lenalidomide in Combination With R-GemOx in First-line Treatment of Elderly Diffuse Large B Cell Lymphoma |
|
|
| Recruiting | N/A | 124 | RoW | Lenalidomide, Rituximab, Gemcitabine, oxaliplatin | The First Affiliated Hospital with Nanjing Medical University | Diffuse Large B Cell Lymphoma | 12/22 | 12/24 | | |
| Recruiting | N/A | 286 | RoW | Antiarrhythmic drug including Propafenone, Sotalol, Dronedarone and Amiodarone, cryoballoon ablation | Ruijin Hospital | Atrial Fibrillation, Persistent, Arrhythmias, Cardiac | 07/25 | 01/26 | | |
NCT05777369: R-CMOP in Patients With Primary Diffuse Large B-cell Lymphoma |
|
|
| Not yet recruiting | N/A | 30 | NA | Rituximab, Mitoxantrone hydrochloride liposome, Cyclophosphamide, Vincristine/Vindesine, Prednisone | The First Affiliated Hospital with Nanjing Medical University | Diffuse Large B-cell Lymphoma | 08/23 | 08/24 | | |
| Recruiting | N/A | 50 | RoW | Chi-GVM, Chidamide Combined With Gemcitabine, Vinorelbine, and Mitoxantrone Hydrochloride Liposome | The First Affiliated Hospital with Nanjing Medical University | Relapsed/Refractory Peripheral T-cell Lymphoma | 09/25 | 09/25 | | |
| Not yet recruiting | N/A | 60 | NA | Rituximab, Mitoxantrone hydrochloride liposome, Isophosphamide, Etoposide, X: Orelabrutinib, X: Chidamide, X: Penpulimab, X: Lenalidomide | The First Affiliated Hospital with Nanjing Medical University | Diffuse Large B-cell Lymphoma | 01/24 | 01/25 | | |
NCT05198674: SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN |
|
|
| Recruiting | N/A | 1400 | Europe, US, RoW | Renal Denervation (Symplicity Spyral™), Renal Angiography, Renal Denervation | Medtronic Vascular | Hypertension, Vascular Diseases, Cardiovascular Diseases, Chronic Kidney Diseases, Diabetes Mellitus | 11/26 | 11/29 | | |
| Not yet recruiting | N/A | 768 | RoW | early pancreatic stent placement (EPSP), late pancreatic stent placement (EPSP) | The First Affiliated Hospital of Anhui Medical University, First Affiliated Hospital Bengbu Medical College, Anqing Municipal Hospital, First Affiliated Hospital of Wannan Medical College, Tongcheng People's Hospital of Anhui province, Fuyang people's hospital | Cholangiopancreatography, Endoscopic Rretrograde, Post-ERCP Pancreatitis | 03/26 | 03/26 | | |
| Recruiting | N/A | 380 | Canada, US | Arm 1: treatment with Neovasc Reducer, Arm 2 (control): Implantation procedure with no device implanted, Arm 3 (unblinded, non-randomized): Single arm registry | Neovasc Inc., Shockwave Medical, Inc. | Refractory Angina | 06/25 | 12/28 | | |
NCT05426824: The Whole-course Management of Pegaspargase in ENKTL |
|
|
| Not yet recruiting | N/A | 72 | RoW | Pegaspargase（P-GOD）, Pegaspargase（PEMD） | The First Affiliated Hospital with Nanjing Medical University | Extranodal NK/T Cell Lymphoma | 07/24 | 07/25 | | |
NCT04837222: A Study of Brentuximab Vedotin in Adults With CD30-positive Lymphoma |
|
|
| Active, not recruiting | N/A | 1000 | RoW | No Intervention | Takeda | Lymphoma | 06/26 | 06/26 | | |
NCT05896813: CMOP Regimen and Chidamide in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma |
|
|
| Recruiting | N/A | 30 | RoW | CMOP+Chidamide | The First Affiliated Hospital with Nanjing Medical University | Newly Diagnosed Peripheral T-cell Lymphoma | 01/25 | 01/25 | | |
| Active, not recruiting | N/A | 399 | Europe, US | Shockwave Medical Coronary IVL System | Shockwave Medical, Inc. | Coronary Artery Disease | 12/24 | 04/28 | | |
NCT05343377: A Clinical Study of the Value of Circulating Free Methylated EBV DNA in Extranodal NK/T Cell Lymphoma |
|
|
| Not yet recruiting | N/A | 72 | RoW | circulate free methylated EBV DNA | The First Affiliated Hospital with Nanjing Medical University, Zhenjiang First People's Hospital, Changzhou First People's Hospital, Changzhou Second People's Hospital, Wuxi People's Hospital, Second Affiliated Hospital of Soochow University, The First Affiliated Hospital of Nantong University, Huaian first people's hospital, Yancheng First People's Hospital | Extranodal Natural Killer/T-cell Lymphoma | 06/25 | 06/28 | | |
NCT06120426: En Bloc Resection Versus Separation Surgery Combined With Radiotherapy for the Treatment of Spinal Oligometastatic Tumor. |
|
|
| Recruiting | N/A | 182 | RoW | total en bloc spondylectomy | Shanghai Changzheng Hospital, Peking University Third Hospital, Peking University People's Hospital, Henan Cancer Hospital, First Affiliated Hospital, Sun Yat-Sen University, Sun Yat-sen University, Zhejiang University, Tianjin Hospital, The First Affiliated Hospital of Nanchang University, The Third Affiliated Hospital of Southern Medical University | Spinal Metastases, Spinal Tumor, Radiotherapy, Malignant Bone Tumor, Surgery | 07/25 | 07/27 | | |
NCT05677100: Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure |
|
|
| Recruiting | N/A | 268 | US | Aortix System, Aortix Pump | Procyrion | Heart Failure, Cardiorenal Syndrome, Cardio-Renal Syndrome, ADHF, Heart Failure, Systolic, Heart Failure, Diastolic, Heart Failure; With Decompensation, Heart Failure, Congestive | 07/25 | 12/25 | | |
NCT05967949: A Retrospective Clinical Study on the First-line Maintenance Treatment of PTCL With Chidamide. |
|
|
| Recruiting | N/A | 200 | RoW | chidamide | The First Affiliated Hospital with Nanjing Medical University | PTCL | 04/26 | 04/28 | | |
NCT05645302: Intensive Monitoring Scheme of Lidocaine Cataplasms |
|
|
| Recruiting | N/A | 200 | RoW | Lidocaine Cataplasms | Qianfoshan Hospital | Adverse Reaction to Drug | 10/22 | 12/22 | | |
| Raval, Nirav Y |
NCT05258942: MyLeukoMAPâ„¢ Genomic Survival Prediction Assay Pivotal Clinical Study |
|
|
| Recruiting | N/A | 300 | US | Observational | LeukoLifeDx Inc | Heart Failure | 06/23 | 08/23 | | |
NCT05677100: Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure |
|
|
| Recruiting | N/A | 268 | US | Aortix System, Aortix Pump | Procyrion | Heart Failure, Cardiorenal Syndrome, Cardio-Renal Syndrome, ADHF, Heart Failure, Systolic, Heart Failure, Diastolic, Heart Failure; With Decompensation, Heart Failure, Congestive | 07/25 | 12/25 | | |
| Hansen, Jennifer |
NCT05677100: Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure |
|
|
| Recruiting | N/A | 268 | US | Aortix System, Aortix Pump | Procyrion | Heart Failure, Cardiorenal Syndrome, Cardio-Renal Syndrome, ADHF, Heart Failure, Systolic, Heart Failure, Diastolic, Heart Failure; With Decompensation, Heart Failure, Congestive | 07/25 | 12/25 | | |
| Minear, Steven |
NCT03310125 / 2017-003836-35: Colchicine For The Prevention Of Perioperative Atrial Fibrillation In Patients Undergoing Thoracic Surgery (COP-AF) |
|
|
| Completed | 3 | 3209 | Europe, Canada, US, RoW | Colchicine, Placebo | Population Health Research Institute, Hamilton Health Sciences Corporation | Atrial Fibrillation, Atrial Flutter, Myocardial Injury After Non-Cardiac Surgery | 07/23 | 07/23 | | |
NCT04084548: Perioperative Lidocaine and Ketamine in Abdominal Surgery |
|
|
| Active, not recruiting | 3 | 420 | US | Lidocaine and ketamine, Lidocaine, Ketamine, Placebo | The Cleveland Clinic | Postoperative Pain | 12/24 | 12/24 | | |
NCT05814016: A Study of Danavorexton in People With Obstructive Sleep Apnea After General Anesthesia for Abdominal Surgery |
|
|
| Terminated | 2 | 41 | US | Danavorexton, TAK-925, Placebo | Takeda | Sleep Apnea | 09/24 | 09/24 | | |
NCT05677100: Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure |
|
|
| Recruiting | N/A | 268 | US | Aortix System, Aortix Pump | Procyrion | Heart Failure, Cardiorenal Syndrome, Cardio-Renal Syndrome, ADHF, Heart Failure, Systolic, Heart Failure, Diastolic, Heart Failure; With Decompensation, Heart Failure, Congestive | 07/25 | 12/25 | | |
NCT04669548: Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry |
|
|
| Recruiting | N/A | 2500 | US | Accuryn Monitoring System | Potrero Medical | Intraabdominal Hypertension, Abdominal Compartment Syndrome, Acute Kidney Injury, Cardiovascular Surgery | 12/26 | 12/26 | | |
| Wu, Robby |
NCT05677100: Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure |
|
|
| Recruiting | N/A | 268 | US | Aortix System, Aortix Pump | Procyrion | Heart Failure, Cardiorenal Syndrome, Cardio-Renal Syndrome, ADHF, Heart Failure, Systolic, Heart Failure, Diastolic, Heart Failure; With Decompensation, Heart Failure, Congestive | 07/25 | 12/25 | | |
| Armijos, Juan |
NCT05104853: Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects with Primary Biliary Cholangitis |
|
|
| Active, not recruiting | 1/2 | 42 | US | CNP-104, Placebo | COUR Pharmaceutical Development Company, Inc. | Primary Biliary Cholangitis | 01/26 | 01/26 | | |
NCT05677100: Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure |
|
|
| Recruiting | N/A | 268 | US | Aortix System, Aortix Pump | Procyrion | Heart Failure, Cardiorenal Syndrome, Cardio-Renal Syndrome, ADHF, Heart Failure, Systolic, Heart Failure, Diastolic, Heart Failure; With Decompensation, Heart Failure, Congestive | 07/25 | 12/25 | | |
| Lahay, Donna |
NCT05198674: SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN |
|
|
| Recruiting | N/A | 1400 | Europe, US, RoW | Renal Denervation (Symplicity Spyral™), Renal Angiography, Renal Denervation | Medtronic Vascular | Hypertension, Vascular Diseases, Cardiovascular Diseases, Chronic Kidney Diseases, Diabetes Mellitus | 11/26 | 11/29 | | |
NCT05677100: Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure |
|
|
| Recruiting | N/A | 268 | US | Aortix System, Aortix Pump | Procyrion | Heart Failure, Cardiorenal Syndrome, Cardio-Renal Syndrome, ADHF, Heart Failure, Systolic, Heart Failure, Diastolic, Heart Failure; With Decompensation, Heart Failure, Congestive | 07/25 | 12/25 | | |
